Home
Bafna Pharmaceuticals Ltd Board of Directors
Board of Directors at Bafna Pharmaceuticals Ltd
A Mohanachandran
Company Sec. & Compli. Officer
Akilapriya Raju
Non-Exec & Non-Independent Dir
Babulal Kumar
Non-Exec. & Independent Dir.
Krishna Yeachuri
Independent Director
Palamadai Sundaresan
Non-Exec. & Independent Dir.
Key Highlights
- Shanmugam Hemalatha joins the board as E D & Wholetime Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vinayak Dinesh Dendukuri joins the board as ED / WTD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Upendar Mekala Reddy joins the board as Non-Exec & Non-Independent Dir, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ravichandran Chitra joins the board as Chairman & Independent Directo, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Navin Kumar joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 26 Dec 2025 | 164.2 |
| 24 Dec 2025 | 172 |
| 23 Dec 2025 | 164.95 |
| 22 Dec 2025 | 157.1 |
| 19 Dec 2025 | 149.65 |
| 18 Dec 2025 | 148 |
| 17 Dec 2025 | 148 |
| 16 Dec 2025 | 146.05 |
| 15 Dec 2025 | 149 |
| 12 Dec 2025 | 146.35 |
Company Fundamentals for Bafna Pharmaceuticals Ltd
Market Cap
388 Cr
EPS
4.5
P/E Ratio (TTM)
36.7
P/B Ratio (TTM)
4.3
Day’s High
177.95
Day’s Low
163.4
DTE
0.4
ROE
11.6
52 Week High
204.95
52 Week Low
67.8
ROCE
11.0
Market Price of Bafna Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Bafna Pharmaceuticals Ltd News Hub
Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter
Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains
Read more
13 Aug 24
Bafna Pharmaceuticals to declare Quarterly Result
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
10 Aug 24
Bafna Pharmaceuticals to convene AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
04 Sept 24
Bafna Pharmaceuticals schedules AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
05 Sept 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Bafna Pharmaceuticals Ltd
How are members of Bafna Pharmaceuticals Ltd Board of Directors selected?
Members of the Bafna Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Bafna Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Bafna Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Bafna Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Bafna Pharmaceuticals Ltd Board of Directors meet?
The Bafna Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Bafna Pharmaceuticals Ltd Board of Directors?
The Bafna Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Bafna Pharmaceuticals Ltd?
The current Board of Directors at Bafna Pharmaceuticals Ltd includes Shanmugam Hemalatha( E D & Wholetime Director) ,Vinayak Dinesh Dendukuri( ED / WTD) ,Upendar Mekala Reddy( Non-Exec & Non-Independent Dir) ,Ravichandran Chitra( Chairman & Independent Directo) ,Navin Kumar( Independent Non Exe. Director) . The full list can be found on Bafna Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
